Senior insider sale
CEO and President at RECURSION PHARMACEUTICALS, INC. — senior position signals high conviction
$548.6K
124.40K shares
What this filing means
KHAN NAJAT plans to sell 124.40K shares of RECURSION PHARMACEUTICALS, INC. valued at approximately $548.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/22/2025ACC: 0001628280-25-058427
DirectorOfficer· CEO and President
Since Feb 2026
124.40K
Shares to sell
$548.6K
Approx. market value
124.40K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Equity Compensation
Equity Compensation
11/15/2025
23.95KEquity Compensation
Equity Compensation
8/15/2025
91.12KEquity Compensation
Equity Compensation
5/15/2025
9.34KTotal acquired124.40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/15/2025 | Equity Compensation Equity Compensation | 23.95K | — |
8/15/2025 | Equity Compensation Equity Compensation | 91.12K | — |
5/15/2025 | Equity Compensation Equity Compensation | 9.34K | — |
| Total | 124.40K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
124.40K
Market value
$548.6K
12/22/2025
Total
Units
124.40K
Value
$548.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/22/2025 | 124.40K | $548.6K | NASDAQ | Planned |
| Total | 124.40K | $548.6K | ||